UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 8, 2016
Accession Number:
0001104659-16-159607
Submission Type:
POS AM
CIK:
0001338042
Company Name:
Aegerion Pharmaceuticals, Inc.
File Number:
333-211462